Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II

PHASE2RecruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 4, 2025

Primary Completion Date

February 1, 2028

Study Completion Date

April 1, 2028

Conditions
Depression
Interventions
DRUG

Propofol

Targeted propofol infusion in TRD patients will induce sedation. Dosage of propofol is determined based upon EEG markers and treatment arm.

DIAGNOSTIC_TEST

Electroencephalography (EEG)

EEG will be recorded during propofol infusion and during overnight sleep. Sleep EEG data will be acquired for a minimum of one night prior to the first sedation session, providing a baseline measure. Additional overnight sleep recordings will be performed on day of sedation and subsequent nights.

BEHAVIORAL

Brief Behavioral Therapy for Insomnia

Trained staff will provide evaluation and up to 3 follow up appointments of BBTI for all participants. These will be done remotely to assess behavioral approaches to improve overall sleep habits.

Trial Locations (1)

63110

RECRUITING

Washington University School of Medicine/Barnes-Jewish Hospital, St Louis

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Washington University School of Medicine

OTHER